Outcomes of monthly video consultations as an add-on to regular care for children with type 1 diabetes : A 6-month quasi-randomized clinical trial followed by an extension phase
© 2020 John Wiley & Sons A/S . Published by John Wiley & Sons Ltd..
OBJECTIVE: To explore the outcomes of monthly video consultations for children with diabetes.
METHODS: The Virtual Outpatient Diabetes Clinic for Children and Youth (VIDIKI) was a 6-month multicenter controlled clinical trial followed by an extension phase. The 240 participants (1-16 years), all using a CGM, were quasi-randomized by residence location to the intervention group (IG) or the waitlist-control group (WG). The IG started immediately after enrollment with monthly video consultations as an add-on to regular care, while the WG received regular care for 6 months before starting the intervention. The extension phase lasted between 12 months and 2 years, depending on the enrollment date. Linear regression was applied to model the primary outcome of HbA1c after 6 months and other metabolic and psychosocial outcomes.
RESULTS: After covariate adjustments, the HbA1c at 6 months-corresponding to the controlled treatment phase-was 0.11% lower in the IG than that in the WG (95% CI -0.31 to 0.09, P = .277). For the total study sample, a significant HbA1c improvement was found after 12 months of video consultations, which increased further until month 15. The diabetes burden of the main caregivers was lower, and parental treatment satisfaction was significantly higher in the IG than that in the WG.
CONCLUSIONS: The VIDIKI study found no significant HbA1c difference between IG and WG after 6 months in the controlled phase, but there was a decreased diabetes burden and increased treatment satisfaction for the parents. In the longitudinal perspective, a significant HbA1c improvement was found after 12 and 15 months.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
|---|---|
| Enthalten in: |
Pediatric diabetes - 21(2020), 8 vom: 02. Dez., Seite 1502-1515 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
von Sengbusch, Simone [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Blood Glucose |
|---|
| Anmerkungen: |
Date Completed 30.09.2021 Date Revised 30.09.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/pedi.13133 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM315799897 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM315799897 | ||
| 003 | DE-627 | ||
| 005 | 20231225155710.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/pedi.13133 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1052.xml |
| 035 | |a (DE-627)NLM315799897 | ||
| 035 | |a (NLM)33009690 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a von Sengbusch, Simone |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Outcomes of monthly video consultations as an add-on to regular care for children with type 1 diabetes |b A 6-month quasi-randomized clinical trial followed by an extension phase |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.09.2021 | ||
| 500 | |a Date Revised 30.09.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 John Wiley & Sons A/S . Published by John Wiley & Sons Ltd. | ||
| 520 | |a OBJECTIVE: To explore the outcomes of monthly video consultations for children with diabetes | ||
| 520 | |a METHODS: The Virtual Outpatient Diabetes Clinic for Children and Youth (VIDIKI) was a 6-month multicenter controlled clinical trial followed by an extension phase. The 240 participants (1-16 years), all using a CGM, were quasi-randomized by residence location to the intervention group (IG) or the waitlist-control group (WG). The IG started immediately after enrollment with monthly video consultations as an add-on to regular care, while the WG received regular care for 6 months before starting the intervention. The extension phase lasted between 12 months and 2 years, depending on the enrollment date. Linear regression was applied to model the primary outcome of HbA1c after 6 months and other metabolic and psychosocial outcomes | ||
| 520 | |a RESULTS: After covariate adjustments, the HbA1c at 6 months-corresponding to the controlled treatment phase-was 0.11% lower in the IG than that in the WG (95% CI -0.31 to 0.09, P = .277). For the total study sample, a significant HbA1c improvement was found after 12 months of video consultations, which increased further until month 15. The diabetes burden of the main caregivers was lower, and parental treatment satisfaction was significantly higher in the IG than that in the WG | ||
| 520 | |a CONCLUSIONS: The VIDIKI study found no significant HbA1c difference between IG and WG after 6 months in the controlled phase, but there was a decreased diabetes burden and increased treatment satisfaction for the parents. In the longitudinal perspective, a significant HbA1c improvement was found after 12 and 15 months | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a CGM | |
| 650 | 4 | |a telemedicine | |
| 650 | 4 | |a type 1 diabetes | |
| 650 | 4 | |a video consultation | |
| 650 | 7 | |a Blood Glucose |2 NLM | |
| 700 | 1 | |a Eisemann, Nora |e verfasserin |4 aut | |
| 700 | 1 | |a Mueller-Godeffroy, Esther |e verfasserin |4 aut | |
| 700 | 1 | |a Lange, Karin |e verfasserin |4 aut | |
| 700 | 1 | |a Doerdelmann, Jana |e verfasserin |4 aut | |
| 700 | 1 | |a Erdem, Alev |e verfasserin |4 aut | |
| 700 | 1 | |a Menrath, Ingo |e verfasserin |4 aut | |
| 700 | 1 | |a Bokelmann, Jessica |e verfasserin |4 aut | |
| 700 | 1 | |a Krasmann, Miriam |e verfasserin |4 aut | |
| 700 | 1 | |a Kaczmarczyk, Patrizia |e verfasserin |4 aut | |
| 700 | 1 | |a Bertram, Bettina |e verfasserin |4 aut | |
| 700 | 1 | |a Hiort, Olaf |e verfasserin |4 aut | |
| 700 | 1 | |a Katalinic, Alexander |e verfasserin |4 aut | |
| 700 | 1 | |a Frielitz, Fabian S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pediatric diabetes |d 2000 |g 21(2020), 8 vom: 02. Dez., Seite 1502-1515 |w (DE-627)NLM14370222X |x 1399-5448 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2020 |g number:8 |g day:02 |g month:12 |g pages:1502-1515 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/pedi.13133 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2020 |e 8 |b 02 |c 12 |h 1502-1515 | ||